In vivo studies using mice models of Psoriasis showed that miR-146a inhibition promoted earlier psoriasis-like onset, epidermal hyperproliferation, IL-17 skin inflammation and IL-8 secretion with the increased infiltration of neutrophils at lesion sites. The gene discussed is IL17A; the disease is psoriasis.